IP Library Granted Patent US 8,246,576
Granted Patent B2
US 8,246,576 · App. 12/774,954 · Granted Aug 21, 2012

Method and apparatus for delivery of a therapeutic agent with an expandable medical device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,246,576
App. No.
12/774,954
Granted
Aug 21, 2012
Kind
B2
Abstract

Described herein is a medical device that has a collapsed configuration and an expanded configuration wherein one or more polymeric network layers are applied to the substrate and microparticles embedded in the polymeric network. The polymeric network layer or layers is/are configured to retain the microparticles when the device is in a collapsed configuration and to release the microparticles when the device is in an expanded configuration. Methods for delivering a therapeutic agent using the device and making the device are also disclosed.

Claims (12)

1. An expandable medical device comprising:

(a) an expandable substrate having a collapsed configuration and an expanded configuration;

(b) a polymeric coating on the expandable substrate, wherein the polymeric coating forms a network attached to at least a portion of the expandable substrate, wherein the polymeric network includes polymeric fibers that define pores having a first effective pore diameter when the expandable substrate is in a collapsed configuration; and

(c) microparticle carriers for one or more therapeutic agents, wherein the microparticles have an average diameter sufficient to be entrapped within the network when the expandable substrate is collapsed and wherein the microparticles are released from the network when the expandable substrate is in the expanded configuration, wherein at least some of the polymeric fibers are configured to rupture upon expansion of the device and release the microparticles.

2. The expandable medical device of claim 1 , wherein the expandable substrate comprises an intravascular device.

3. The expandable medical device of claim 2 , wherein the intravascular device is selected from the group consisting of: an angioplasty catheter, a stent and an occlusion device.

4. The expandable medical device of claim 1 , wherein the first effective pore diameter is less than the average microparticle diameter.

5. The expandable medical device of claim 1 , wherein the pore diameter of the polymeric network increases upon expansion of the expandable substrate to a second effective pore diameter and thereby releases the microparticles.

6. The expandable medical device of claim 5 , wherein the second effective pore diameter of the network is greater than the first effective pore diameter.

7. The expandable medical device of claim 5 , wherein the second effective pore diameter of the network is greater than the average microparticle diameter.

8. The expandable medical device of claim 1 , wherein the polymeric network is constructed from a hydrophobic material and the microparticles comprise a hydrophilic material such that the microparticles are not retained within the network when the device is in the expanded configuration.

9. The expandable medical device of claim 1 , further comprising a topcoat layer of a second polymeric network.

Assignments (5)
SECURITY INTEREST Recorded Jan 21, 2026
From: SURMODICS MD, LLC
To: BANK OF MONTREAL, AS COLLATERAL AGENT
Reel/Frame 074461/0199 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2025
From: SURMODICS, INC.
To: SURMODICS MD, LLC
Reel/Frame 073894/0058 →
RELEASE OF SECURITY INTEREST Recorded Nov 24, 2025
From: MIDCAP FUNDING IV TRUST
To: SURMODICS, INC.; SURMODICS SHARED SERVICES, LLC; SURMODICS HOLDINGS, LLC; SURMODICS COATINGS, LLC; SURMODICS MD, LLC; SURMODICS COATINGS MFG, LLC; SURMODICS IVD, INC.; SURMODICS MD OPERATIONS, LLC; NORMEDIX, INC.
Reel/Frame 073690/0186 →
SECURITY INTEREST Recorded Aug 23, 2024
From: SURMODICS, INC.; SURMODICS SHARED SERVICES, LLC; SURMODICS HOLDINGS, LLC; SURMODICS COATINGS, LLC; SURMODICS MD, LLC; SURMODICS COATINGS MFG, LLC; SURMODICS IVD, INC.; SURMODICS MD OPERATIONS, LLC; NORMEDIX, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 068762/0423 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2010
From: SLAGER, JORAM
To: SURMODICS, INC.
Reel/Frame 024501/0421 →